• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec10
Journey Medical Corporation Announces Phase I Trial Results for Emrosi™
13:30
Nov13
Journey Medical released FY2025 Q3 earnings on November 12 After-Market EST, actual revenue USD 17.63 M (forecast USD 18.85 M), actual EPS USD -0.0927 (forecast USD -0.0375)
00:00
Journey Medical released FY2025 9 Months Earnings on November 12 After-Market EST, with actual revenue of USD 45.78 M and EPS of USD -0.4358
00:00
Nov5
Journey Medical to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast Revenue USD 18.85 M, EPS USD -0.0375
00:06
Aug12
Journey Medical released FY2025 Q2 earnings on August 12 After-Market EST, actual revenue USD 15.01 M (forecast USD 14.8 M), actual EPS USD -0.1629 (forecast USD -0.105)
23:00
Journey Medical released FY2025 Semi-Annual earnings on August 12 After-Market EST, actual revenue USD 28.15 M, actual EPS USD -0.3428
23:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 17.63 M, Net Income -2.315 M, EPS -0.0927

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 15.01 M, Net Income -3.796 M, EPS -0.1629

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 13.14 M, Net Income -4.073 M, EPS -0.1801

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATPC
0.1339
+96.91%
+0.066
BTTC
6.130
+84.92%
+2.825
PETS
3.260
+84.18%
+1.482
AXIL
8.490
+69.12%
+3.340
BEAT
2.320
+49.68%
+0.770
SMX
214.370
+46.53%
+68.070
DHIL
170.260
+44.93%
+52.780
MIGI
9.360
+39.70%
+2.635
GEMG
8.780
+37.98%
+2.417
PL
17.187
+32.82%
+4.250
View More